在股东批准之后,Caladrius董事会批准了Caladrius普通股的反向股票拆分,比例为每15股发行在外的股票换1股新股。
合并后的公司将更名为...查看全文
牛股小红书2022-04-28 13:52
临床阶段生物技术公司$Caladrius生物科学(CLBS)$ 与私营企业Cend Therapeutics达成的合并协议。
根据协议条款,Cend将与Caladrius(CLBS)的一个子公司进行全股票交易合并,合并后的公司Lisata Therapeutics将在纳斯达克上市,股票代码为“LSTA”
因此,卡拉德里乌斯(CLBS)首席执行官戴...查看全文
Edward16992021-02-19 19:25
$Caladrius生物科学(CLBS)$ 两个产品一个在日本的phase 2,一个在美国的phase 2b。很大的upside potential。查看全文
Richardlim2021-01-21 02:07
$Tengasco(TGC)$ 起飞了?
向前辈学习 $Obalon Therapeutics(OBLN)$ $Caladrius生物科学(CLBS)$查看全文
$Caladrius Biosciences, Inc.(CLBS)$ EFFECT - Notice of Effectiveness Filed: 2016-12-19 AccNo: 9999999995-16-006494 Size: 2 KB 网页链接
$Caladrius Biosciences, Inc.(CLBS)$ 内部交易: 2016-11-21,Director,Wei Eric ,卖出,500普通股, $4.20
$Caladrius Biosciences, Inc.(CLBS)$ S-3 - Registration statement under Securities Act of 1933 Filed: 2016-11-15 AccNo: 0000320017-16-000166 Size: 235 KB 网页链接
$Caladrius Biosciences, Inc.(CLBS)$ 8-K - Current report Filed: 2016-11-07 AccNo: 0000320017-16-000163 Size: 4 MBItem 2.02: Results of Operations and Financial ConditionItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$Caladrius Biosciences, Inc.(CLBS)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2016-11-07 AccNo: 0000320017-16-000162 Size: 5 MB 网页链接
$Caladrius Biosciences, Inc.(CLBS)$ 美东时间 2016-11-07 16:30 After Market Close:CALADRIUS BIOSC Earning Release . Wall St EPS Est ($):-1.23. 网页链接
$Caladrius Biosciences, Inc.(CLBS)$ 8-K - Current report Filed: 2016-10-19 AccNo: 0000320017-16-000159 Size: 4 MBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$Caladrius Biosciences, Inc.(CLBS)$ 8-K - Current report Filed: 2016-10-12 AccNo: 0000320017-16-000155 Size: 37 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 9...
$Caladrius Biosciences, Inc.(CLBS)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2016-09-26 AccNo: 0001144204-16-125352 Size: 67 KB 网页链接
$Caladrius Biosciences, Inc.(CLBS)$ D - Notice of Exempt Offering of Securities Filed: 2016-09-26 AccNo: 0000320017-16-000153 Size: 14 KB 网页链接